Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 93.48%-1.92M | ---- | -31.99%-29.41M | ---- | -119.78%-22.28M | ---- | -96.43%-10.14M | ---- | 92.28%-5.16M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 97.83%-5K | ---- | 10.16%-230K | ---- | -194.25%-256K | ---- | -1,142.86%-87K | ---- | 97.85%-7K |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 950.00%84K | ---- | -89.61%8K |
| Impairment and provisions: | ---- | -100.76%-99K | ---- | 275.88%12.98M | ---- | -7.87%3.45M | ---- | -41.97%3.75M | ---- | -79.62%6.46M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | 463.58%4.5M | ---- | -63.16%799K | ---- | -13.93%2.17M | ---- | -57.88%2.52M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | --473K | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -101.17%-99K | ---- | 288.63%8.48M | ---- | 38.10%2.18M | ---- | -59.91%1.58M | ---- | -84.68%3.94M |
| Asset sale loss (gain): | ---- | ---30K | ---- | ---- | ---- | 100.43%14K | ---- | ---3.26M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | --14K | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---30K | ---- | ---- | ---- | ---- | ---- | ---3.26M | ---- | ---- |
| Depreciation and amortization: | ---- | -97.94%93K | ---- | -33.70%4.51M | ---- | 63.34%6.81M | ---- | -14.59%4.17M | ---- | -80.66%4.88M |
| -Depreciation | ---- | -99.32%7K | ---- | 147.71%1.03M | ---- | -55.99%415K | ---- | -42.78%943K | ---- | -77.83%1.65M |
| -Amortization of intangible assets | ---- | ---- | ---- | -58.23%33K | ---- | -37.30%79K | ---- | -8.70%126K | ---- | -88.46%138K |
| Financial expense | ---- | -51.66%438K | ---- | -6.89%906K | ---- | 15.83%973K | ---- | -10.16%840K | ---- | -51.88%935K |
| Special items | ---- | -1,507.05%-6.38M | ---- | -54.47%-397K | ---- | 93.27%-257K | ---- | 38.13%-3.82M | ---- | -2,929.82%-6.17M |
| Operating profit before the change of operating capital | ---- | 32.09%-7.9M | ---- | -0.76%-11.63M | ---- | -36.43%-11.55M | ---- | -993.56%-8.46M | ---- | 111.31%947K |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 142.06%4.4M | ---- | 126.68%1.82M | ---- | -7,676.67%-6.82M | ---- | 114.29%90K | ---- | -85.11%42K |
| Accounts receivable (increase)decrease | ---- | -5,067.82%-14.94M | ---- | -641.03%-289K | ---- | -102.74%-39K | ---- | 201.94%1.42M | ---- | -163.33%-1.39M |
| Accounts payable increase (decrease) | ---- | 1,111.79%6.79M | ---- | -39.72%560K | ---- | 458.69%929K | ---- | 89.42%-259K | ---- | 54.65%-2.45M |
| prepayments (increase)decrease | ---- | 234.83%3.66M | ---- | 171.22%1.09M | ---- | -164.29%-1.54M | ---- | -47.92%2.39M | ---- | 761.90%4.59M |
| Special items for working capital changes | ---- | ---- | ---- | 833.33%2.24M | ---- | 111.76%240K | ---- | ---2.04M | ---- | ---- |
| Cash from business operations | ---- | -28.57%-7.98M | ---- | 66.92%-6.21M | ---- | -173.58%-18.77M | ---- | -495.45%-6.86M | ---- | 114.49%1.74M |
| Other taxs | ---- | 100.26%5K | ---- | -789.05%-1.89M | ---- | 128.16%274K | ---- | -3,238.71%-973K | ---- | 101.34%31K |
| Special items of business | -77.35%135K | ---- | 112.06%596K | ---- | 68.92%-4.94M | ---- | -2,102.49%-15.9M | ---- | -133.27%-722K | ---- |
| Net cash from operations | -77.35%135K | 1.47%-7.98M | 112.06%596K | 56.22%-8.1M | 68.92%-4.94M | -136.10%-18.5M | -2,102.49%-15.9M | -543.60%-7.83M | -133.27%-722K | 112.36%1.77M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -83.33%5K | ---- | 87.50%30K | ---- | -81.61%16K | ---- | 1,142.86%87K | ---- | -97.85%7K |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -69.88%628K |
| Sale of fixed assets | ---- | --30K | ---- | ---- | ---- | ---- | ---- | --34.03M | ---- | ---- |
| Purchase of fixed assets | ---- | 96.88%-57K | ---- | 62.38%-1.82M | ---- | -1,750.76%-4.85M | ---- | -98.48%-262K | ---- | 98.37%-132K |
| Other items in the investment business | ---2K | ---- | ---- | ---- | -12.02%-643K | ---- | -101.70%-574K | ---- | --33.83M | ---- |
| Net cash from investment operations | ---2K | 98.77%-22K | ---- | 62.88%-1.79M | -12.02%-643K | -114.28%-4.83M | -101.70%-574K | 6,630.02%33.85M | 3,612.95%33.83M | -98.30%503K |
| Net cash before financing | -77.68%133K | 19.12%-8M | 110.67%596K | 57.60%-9.89M | 66.10%-5.59M | -189.66%-23.33M | -149.77%-16.48M | 1,046.67%26.02M | 974.42%33.1M | -85.17%2.27M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 60.25%3.81M | ---- | --2.38M | ---- | ---- | ---- | ---- | ---- | --15.5M |
| Refund | ---- | 38.74%-2.37M | ---- | 0.00%-3.88M | ---- | -499.85%-3.88M | ---- | 66.60%-646K | ---- | 74.35%-1.93M |
| Interest paid - financing | ---- | 51.45%-434K | ---- | -132.81%-894K | ---- | 10.49%-384K | ---- | -443.04%-429K | ---- | 68.90%-79K |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | --300K | ---- | ---- | ---- | ---- |
| Other items of the financing business | 194.66%8.57M | ---- | -76.67%-9.05M | ---- | -140.18%-5.12M | ---- | 76.22%-2.13M | ---- | ---8.97M | 75.65%-1.4M |
| Net cash from financing operations | 194.66%8.57M | 89.56%-803K | -76.67%-9.05M | 27.76%-7.69M | -140.18%-5.12M | -4.29%-10.65M | 76.22%-2.13M | -425.41%-10.21M | -38.23%-8.97M | 109.97%3.14M |
| Effect of rate | -159.26%-16K | -1,000.00%-11K | --27K | ---1K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | 202.91%8.7M | 49.93%-8.8M | 21.04%-8.46M | 48.25%-17.58M | 42.46%-10.71M | -314.90%-33.98M | -177.11%-18.61M | 192.45%15.81M | 807.89%24.13M | 133.46%5.41M |
| Begining period cash | -96.71%300K | -65.86%9.11M | -65.86%9.11M | -56.00%26.7M | -56.00%26.7M | 35.24%60.67M | 35.24%60.67M | 13.70%44.86M | 13.70%44.86M | -29.05%39.46M |
| Cash at the end | 1,209.77%8.99M | -96.71%300K | -95.71%686K | -65.86%9.11M | -61.99%15.99M | -56.00%26.7M | -39.03%42.06M | 35.24%60.67M | 91.40%68.99M | 13.70%44.86M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.